Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
1 drugs in development
By Therapeutic Area
top 1
R&D Momentum
40/100
Pipeline Velocity
6/100
Trial Completion Rate
89/100
Pipeline Concentration
100/100
Pipeline Freshness
80/100
Activity
Last 14 days
Advancing Lung Health in Zambia Through Increasing Access to Integrated and Comprehensive Screening, Diagnosis and Management of TB and Other Chronic Respiratory Diseases at Community and Primary Care Levels
A Double-blinded, Randomized, Placebo-controlled Phase II Trial to Assess Extended Safety and Tolerability of Subcutaneous CAP256V2LS and VRC07-523LS in HIV Negative Women
PREGNANT AND PARENTING GIRL PROGRAM EVALUATION
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)